351 related articles for article (PubMed ID: 7531355)
1. Risperidone and clozapine in the treatment of drug-resistant schizophrenia and neuroleptic-induced supersensitivity psychosis.
Chouinard G; Vainer JL; Bélanger MC; Turnier L; Beaudry P; Roy JY; Miller R
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Nov; 18(7):1129-41. PubMed ID: 7531355
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind, controlled trial of risperidone versus clozapine in patients with chronic schizophrenia.
Klieser E; Lehmann E; Kinzler E; Wurthmann C; Heinrich K
J Clin Psychopharmacol; 1995 Feb; 15(1 Suppl 1):45S-51S. PubMed ID: 7537287
[TBL] [Abstract][Full Text] [Related]
3. Schizophrenia and severe tardive dyskinesia responsive to risperidone.
Kopala LC; Honer WG
J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794
[No Abstract] [Full Text] [Related]
4. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment of mood disorders in schizophrenia.
Azorin JM
Acta Psychiatr Scand Suppl; 1995; 388():20-3. PubMed ID: 7541599
[TBL] [Abstract][Full Text] [Related]
6. Risperidone augmentation of clozapine.
McCarthy RH; Terkelsen KG
Pharmacopsychiatry; 1995 Mar; 28(2):61-3. PubMed ID: 7542786
[TBL] [Abstract][Full Text] [Related]
7. Risperidone: clinical safety and efficacy in schizophrenia.
Borison RL; Pathiraja AP; Diamond BI; Meibach RC
Psychopharmacol Bull; 1992; 28(2):213-8. PubMed ID: 1381102
[TBL] [Abstract][Full Text] [Related]
8. Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia.
Miller R; Chouinard G
Biol Psychiatry; 1993 Nov; 34(10):713-38. PubMed ID: 7904833
[TBL] [Abstract][Full Text] [Related]
9. Novel neuroleptics in schizophrenia: theory and clinical relevance.
Remington GJ
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S43-5. PubMed ID: 7533050
[No Abstract] [Full Text] [Related]
10. Effects of risperidone in tardive dyskinesia: an analysis of the Canadian multicenter risperidone study.
Chouinard G
J Clin Psychopharmacol; 1995 Feb; 15(1 Suppl 1):36S-44S. PubMed ID: 7537286
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the pharmacotherapy of schizophrenia.
Meltzer HY; Lee MA; Ranjan R
Acta Psychiatr Scand Suppl; 1994; 384():95-101. PubMed ID: 7533472
[TBL] [Abstract][Full Text] [Related]
12. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
Chouinard G; Jones B; Remington G; Bloom D; Addington D; MacEwan GW; Labelle A; Beauclair L; Arnott W
J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic medication in the treatment of schizophrenia.
Kane JM
Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642
[TBL] [Abstract][Full Text] [Related]
14. Clinical use of the newer antipsychotic drugs.
Perry PJ
Am J Health Syst Pharm; 1995 Feb; 52(3 Suppl 1):S9-14. PubMed ID: 7538437
[TBL] [Abstract][Full Text] [Related]
15. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
Cesková E; Svestka J
Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
[TBL] [Abstract][Full Text] [Related]
16. New antipsychotic medications: do research results relate to clinical practice?
MacEwan GW
Can J Psychiatry; 1993 Sep; 38 Suppl 3():S75-9. PubMed ID: 7504572
[TBL] [Abstract][Full Text] [Related]
17. The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research.
Kerwin RW
Br J Psychiatry; 1994 Feb; 164(2):141-8. PubMed ID: 7513599
[No Abstract] [Full Text] [Related]
18. Risperidone versus clozapine in the treatment of schizophrenic patients with acute symptoms: a double blind, randomized trial.
Heinrich K; Klieser E; Lehmann E; Kinzler E; Hruschka H
Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):129-37. PubMed ID: 7509495
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of a new antipsychotic compound (risperidone): results of a pilot study.
Möller HJ; Pelzer E; Kissling W; Riehl T; Wernicke T
Pharmacopsychiatry; 1991 Nov; 24(6):185-9. PubMed ID: 1725925
[TBL] [Abstract][Full Text] [Related]
20. Dystonic reaction and relapse with clozapine discontinuation and risperidone intiation.
Dickson R; Williams R; Dalby JT
Can J Psychiatry; 1994 Apr; 39(3):184. PubMed ID: 7518338
[No Abstract] [Full Text] [Related]
[Next] [New Search]
